Based in Seattle, Pike Street Capital is a private equity firm focused on lower middle market growth buyouts. Pike Street invests in successful businesses in industrial and other sectors that serve professional customers. A typical investment will have between $4 million and $20 million of EBITDA and revenue between $20 million and $200 million.
- Optics
- Food Distribution
- Industrial Equipment
- Logistics
- Engineering
- Recreational Equipment
- Water Management
- Medical Testing
- Automation
- Supply Chain Management
Leadership
| Name | Title | ||
|---|---|---|---|
| Paul Caragher | Managing Partner |
in/paul-caragher-207a051
|
|
| Managing Partner |
|
|
|
| Managing Partner |
|
|
Recent Transactions involving Pike Street Capital
| Deal | Target | Platform | Buyer | Industry |
|---|---|---|---|---|
US BioTek Laboratories Expands Diagnostic Testing Portfolio with Acquisition of RealTime Laboratories |
RealTime Laboratories |
US BioTek Laboratories |
Capitala GroupPike Street Capital |
Diagnostic Laboratory |
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →